RECURSION PHARMACEUTICALS, INC. (RXRX)

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Jan 7, 2026 · Gibson Christopher sold 40K shares at $4.25/share ($170K); converted 60K shares; gifted 20K shares

Gibson Christopher sold 40K shares at $4.25/share ($170K); converted 60K shares; gifted 20K shares

FORM 4

xslF345X05/wk-form4_1767823462.xmlSEC.gov

Graphics and non-inline formats (not embedded below).